1:53 PM
 | 
Jan 09, 2019
 |  BC Extra  |  Clinical News

Patient receives glioblastoma vaccine under right to try

ERC-USA and the University of California Irvine announced that a patient with recurrent glioblastoma multiforme is receiving therapeutic vaccine ERC1671 under California's right-to-try (RTT) law.

ERC1671 is in a...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >